NEOSTIGMINE METHYLSULFATE

Product NDC
0404-9925
11-digit product format
004049925
Labeler code
0404
Product ID
0404-9925_84fbf39b-c286-4c2e-abb2-7639324c4602
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
neostigmine methylsulfate
Dosage form
INJECTION
Route
INTRAVENOUS
Labeler
Henry Schein, Inc.
Application
ANDA209933
Marketing category
ANDA
Marketing start
2022-01-13
Marketing end
0000-00-00
Substance
NEOSTIGMINE METHYLSULFATE
Active strength
1 mg/mL
Pharmacologic classes
Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0404-9925NEOSTIGMINE METHYLSULFATE INJECTION [HENRY SCHEIN, INC.]5Legacy NDC20250112_5f540e86-2a56-4cc0-8f69-64f051830a3d.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
0404-9925-10004049925101 VIAL, MULTI-DOSE in 1 BAG (0404-9925-10) > 10 mL in 1 VIAL, MULTI-DOSE2022-01-130000-00-00NoNoCurrent